Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method Cover

.blurhash-client-img { display: none !important; }

Quantitative analysis and pharmacokinetic study of a novel diarylurea EGFR inhibitor (ZCJ14) in rat plasma using a validated LC-MS/MS method

Acta Pharmaceutica

Volume 71 (2021): Issue 3 (September 2021)

By: Sai-Jie Zuo, Xiao-Liang Cheng, Dong-Zheng Liu, Wei-Yi Feng, Yong-Xiao Cao and San-Qi Zhang

Open Access

|Dec 2020

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/acph-2021-0024 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 415 - 428

Accepted on: Aug 4, 2020

Published on: Dec 31, 2020

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

epidermal growth factor receptor inhibitor,

pharmacokinetics,

bioavailability

Related subjects:

Pharmacy, other

© 2020 Sai-Jie Zuo, Xiao-Liang Cheng, Dong-Zheng Liu, Wei-Yi Feng, Yong-Xiao Cao, San-Qi Zhang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 71 (2021): Issue 3 (September 2021)Next article